The project aims to improve this crop to reduce growers reliance on pesticides and excessive application of fertilizers.
The Joint Venture will initially focus on building out an approximate 2,000 square foot facility at Abba’s Pickering cannabis grow facility, to house a cannabis oil extraction operation focused on producing the oils and extracts currently permitted under ACMPR.
Preliminary studies indicate that cannabinoids can increase the potency and decrease the minimal required therapeutic dosages of antibacterial agents
This collaborative agreement will focus on researching and developing safer pharmaceutical cannabis-based products and moving these products through clinical trials using FDA guidelines.
Professor Raphael Mechoulam, a cannabis research pioneer, has just received funding to identify a possible inhibitory effect of a derivative of cannabidiol on allergic airway inflammation.
38% of resident physicians think medical marijuana is a prescribed substance, while 78% do not know what category medical cannabis falls within the Controlled Substance Act.
The authors of the research also commented on the need for further research stressing that there is a notable lack of studies and a minimal number of the randomized, controlled trials needed to confirm the effectiveness of any treatment.
By determining the optimal amount of fertilizer and developing soilless growing substrates researchers have produced high-yielding plants rich in CBD and THC.
New findings suggest that persistent THC exposure may alter the inhibitory function of VTA GABA cells, increasing dopamine levels and the rewarding features of marijuana.